BENSALEM, Pa. -- (Business Wire)
Law Offices of Howard G. Smith announces an investigation on behalf of
investors of Insys Therapeutics, Inc. (“Insys” or the “Company”)
(NASDAQ: INSY)
investors concerning the Company and its officers’ possible violations
of federal securities laws.
On March 15, 2017, Insys disclosed that it would delay the release of
its financial results for the fourth quarter and full year 2016 in order
to complete an independent review of the Company’s processes related to
sales allowances and extended payment terms. The company further
disclosed that the review could result in a reduction of 2015 net
revenue and pre-tax income.
On this news, shares of Insys fell approximately 5% during intraday
trading on March 16, 2017, thereby injuring investors.
If you purchased Insys securities, have information or would like to
learn more about these claims, or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170324005571/en/
Contacts:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Source: Law Offices of Howard G. Smith
© 2024 Canjex Publishing Ltd. All rights reserved.